Skip to main content
Equibles

DAFNA Capital Management LLC

Position in IMVT — Immunovant, Inc.

CIK 1389933 LOS ANGELES, CA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,761,159
+$2,022,143 QoQ
Shares Held
149,524
-0.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#49
of 226 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. IMVT ranks #15 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 562,630 $105,369,346
2 NKTR
Nektar Therapeutics
 318,380 $22,226,107
3 DNLI
Denali Therapeutics Inc.
 739,014 $19,007,440
4 IDYA
IDEAYA Biosciences, Inc.
 497,240 $18,532,134
5 XENE
Xenon Pharmaceuticals Inc.
 250,772 $15,136,597
6 CYTK
Cytokinetics Inc
 171,998 $14,652,509
7 RCUS
Arcus Biosciences, Inc.
 441,829 $13,621,588
8 ASND
Ascendis Pharma A/S
 48,469 $12,927,651

All Filings in IMVT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,761,159 149,524
2026-03-31 $3,739,016 150,524
2025-12-31 $3,826,320 150,524
2025-09-30 $3,086,867 191,493
2025-06-30 $3,063,888 191,493
2025-03-31 $2,905,231 169,996
2024-12-31 $2,675,060 107,996
2024-09-30 $1,482,405 51,996
2024-06-30 $1,264,982 47,916
2024-03-31 $950,430 29,416
2023-12-31 $1,716,460 40,742
2023-09-30 $863,775 22,500